Takeda and Noile-Immune to jointly develop new CAR-T immunotherapies for cancer

Takeda Pharmaceutical has entered a collaboration with Noile-Immune Biotech to develop next-generation chimeric antigen receptor T-cell (CAR-T) therapy for solid tumours.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news